ondansetron has been researched along with Canine Diseases in 5 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess and confirm the effect of ondansetron on behavior suggestive of nausea in dogs with vestibular syndrome." | 9.51 | Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study. ( Charalambous, M; Elliott, J; Foth, S; Henze, L; Kenward, H; Meller, S; Pelligand, L; Twele, F; Volk, HA, 2022) |
| "To compare effectiveness of maropitant and ondansetron in preventing preoperative vomiting and nausea in healthy dogs premedicated with a combination of hydromorphone, acepromazine, and glycopyrrolate." | 9.41 | Effectiveness of orally administered maropitant and ondansetron in preventing preoperative emesis and nausea in healthy dogs premedicated with a combination of hydromorphone, acepromazine, and glycopyrrolate. ( Burke, JE; Hess, RS; Silverstein, DC, 2021) |
| "To evaluate the incidence of tranexamic acid (TXA)-induced nausea and vomiting after the prophylactic use of 2 antiemetics, ondansetron and maropitant, compared with saline." | 9.34 | Prospective, controlled, blinded, randomized crossover trial evaluating the effect of maropitant versus ondansetron on inhibiting tranexamic acid-evoked emesis. ( Bettschart-Wolfensberger, R; Hartnack, S; Kantyka, ME; Kutter, APN; Meira, C, 2020) |
| "The aim of the study was to evaluate the efficiencies of selected anti-emetic drugs (metoclopramide, ondansetron and maropitant) in preventing vomiting in the treatment of canine parvoviral enteritis." | 9.24 | Comparative efficacy of metoclopramide, ondansetron and maropitant in preventing parvoviral enteritis-induced emesis in dogs. ( Keser, GO; Yalcin, E, 2017) |
| "To assess and confirm the effect of ondansetron on behavior suggestive of nausea in dogs with vestibular syndrome." | 5.51 | Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study. ( Charalambous, M; Elliott, J; Foth, S; Henze, L; Kenward, H; Meller, S; Pelligand, L; Twele, F; Volk, HA, 2022) |
| "To compare effectiveness of maropitant and ondansetron in preventing preoperative vomiting and nausea in healthy dogs premedicated with a combination of hydromorphone, acepromazine, and glycopyrrolate." | 5.41 | Effectiveness of orally administered maropitant and ondansetron in preventing preoperative emesis and nausea in healthy dogs premedicated with a combination of hydromorphone, acepromazine, and glycopyrrolate. ( Burke, JE; Hess, RS; Silverstein, DC, 2021) |
| "To evaluate the incidence of tranexamic acid (TXA)-induced nausea and vomiting after the prophylactic use of 2 antiemetics, ondansetron and maropitant, compared with saline." | 5.34 | Prospective, controlled, blinded, randomized crossover trial evaluating the effect of maropitant versus ondansetron on inhibiting tranexamic acid-evoked emesis. ( Bettschart-Wolfensberger, R; Hartnack, S; Kantyka, ME; Kutter, APN; Meira, C, 2020) |
| "The aim of the study was to evaluate the efficiencies of selected anti-emetic drugs (metoclopramide, ondansetron and maropitant) in preventing vomiting in the treatment of canine parvoviral enteritis." | 5.24 | Comparative efficacy of metoclopramide, ondansetron and maropitant in preventing parvoviral enteritis-induced emesis in dogs. ( Keser, GO; Yalcin, E, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burke, JE | 1 |
| Hess, RS | 1 |
| Silverstein, DC | 1 |
| Villedieu, E | 1 |
| Robinson, W | 1 |
| Shales, C | 1 |
| Henze, L | 1 |
| Foth, S | 1 |
| Meller, S | 1 |
| Twele, F | 1 |
| Charalambous, M | 1 |
| Kenward, H | 1 |
| Elliott, J | 1 |
| Pelligand, L | 1 |
| Volk, HA | 1 |
| Kantyka, ME | 1 |
| Meira, C | 1 |
| Bettschart-Wolfensberger, R | 1 |
| Hartnack, S | 1 |
| Kutter, APN | 1 |
| Yalcin, E | 1 |
| Keser, GO | 1 |
4 trials available for ondansetron and Canine Diseases
| Article | Year |
|---|---|
Effectiveness of orally administered maropitant and ondansetron in preventing preoperative emesis and nausea in healthy dogs premedicated with a combination of hydromorphone, acepromazine, and glycopyrrolate.
Topics: Acepromazine; Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Glycopyrrolate; Hydromor | 2021 |
Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study.
Topics: Animals; Antiemetics; Arginine Vasopressin; Cross-Over Studies; Dog Diseases; Dogs; Double-Blind Met | 2022 |
Prospective, controlled, blinded, randomized crossover trial evaluating the effect of maropitant versus ondansetron on inhibiting tranexamic acid-evoked emesis.
Topics: Animals; Antiemetics; Antifibrinolytic Agents; Cross-Over Studies; Dog Diseases; Dogs; Double-Blind | 2020 |
Comparative efficacy of metoclopramide, ondansetron and maropitant in preventing parvoviral enteritis-induced emesis in dogs.
Topics: Animals; Antiemetics; Dog Diseases; Dogs; Female; Male; Metoclopramide; Ondansetron; Parvoviridae In | 2017 |
1 other study available for ondansetron and Canine Diseases
| Article | Year |
|---|---|
Suspected Obstructive Sleep Apnea Successfully Treated with Ondansetron in a Pug.
Topics: Airway Obstruction; Animals; Craniosynostoses; Dog Diseases; Dogs; Ondansetron; Sleep Apnea, Obstruc | 2022 |